Available Downloads
The Paradigm Shift in Tumor Genotyping
Rapid Detection of 68 Mutations Across 14 Oncogenes from 1 Tumor Specimen
GenPath introduces OnkoMatch, a proprietary assay utilizing SnapShot technology pioneered at Mass General Hospital. OnkoMatch is a reliable and robust tumor genotyping platform for detecting 68 mutations across 14 oncogenes from one specimen.
Add GenPath Oncology to your Inbox!
Subscribe to our e-Newsletters to get our new products, innovations and updates delivered to your inbox.
Subscribe to our e-Newsletters to get our new products, innovations and updates delivered to your inbox.
Search Criteria
1. Choose a Disease State
Breast
Colorectal
Gastrointestinal
Head and Neck
Lung
Melanoma
Ovarian
Pancreatic
Thyroid
2. Choose an Oncogene
AKT
APC
BRAF
CTNNB1
EGFR
IDH1
KIT
KRAS
MAP2K1
NOTCH1
NRAS
PIK3CA
PTEN
TP53
Results
(*Search results are queried from ClinicalTrials.gov)
(*Search results are queried from ClinicalTrials.gov)